Pharmaust Overview
- Founded
- 2003

- Status
- Public
- Employees
- 52

- Stock Symbol
- PAA

- Investments
- 2
- Share Price
- $0.08
- (As of Monday Closing)
Pharmaust General Information
Description
PharmAust Ltd operates as a drug discovery and development company in Australia, Switzerland, and internationally. It develops drug discovery intellectual property for the treatment of various cancers in humans and animals. The company offers Monepantel and Albendazole, which are in Phase II clinical trials for the treatment of cancer. It also provides medicinal and synthetic chemistry services on a contract basis to the drug discovery and pharmaceutical industries.
Contact Information
- 1 Freshwater Parade
- Suite 39
- Claremont, Western Australia 6010
- Australia
Pharmaust Stock Performance
(As of Monday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$0.08 | $0.08 | $0.03 - $0.19 | $25.7M | 317M | 659K |
Pharmaust Financials Summary
In Thousands, USD |
TTM 30-Sep-2020 | FY 2020 30-Jun-2020 | FY 2019 30-Jun-2019 | FY 2018 30-Jun-2018 |
---|---|---|---|---|
EV | 27,079 | 31,198 | 5,557 | 3,923 |
Revenue | 2,140 | 2,624 | 2,224 | |
EBITDA | (651) | (964) | (1,868) | |
Net Income | (912) | (1,109) | (1,953) | |
Total Assets | 7,384 | 6,020 | 6,140 | |
Total Debt | 1,011 | 227 | 313 |
Pharmaust Executive Team (2)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Robert Bishop | Executive Director |
Pharmaust Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialPharmaust Acquisitions (2)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
000000 00000000000 | 13-Aug-2013 | 000000000000000000 | 00.00 | Other Healthcare Technology Systems | |
Pela Resources | 10-Sep-2012 | Merger/Acquisition | Precious Metals and Minerals Mining | 000000 0000000 |